Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation

Neoplasia

Volumn 9, Issue 2, 2007, Pages 101-107

  Agarwal, Sunita K ^a,d   Impey, Soren ^b   McWeeney, Shannon ^b   Scacheri, Peter C ^c,e   Collins, Francis S ^c   Goodman, Richard H ^b   Spiegel, Allen M ^d,f   Marx, Stephen J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ChIP; Chromatin immunoprecipitation; MEN1; Multiple endocrine neoplasia; SACO

Indexed keywords

METHIONINE;

ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION;

EID: 33847294682     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06706     Document Type: Article

References (35)

1. Marx SJ (2002). Multiple endocrine neoplasia type 1. In The Genetic Basis of Human Cancer. Vogelstein B and Kinzler KW, Eds. McGraw-Hill, New York, NY. pp. 450-475.
2. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, and Chandrasekharappa SC (1998). Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95, 1630-1634.
3. Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, et al. (2005). Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res 37, 369-374.
4. Chen YX, Yan J, Keeshan K, Tubbs AT, Wang H, Silva A, Brown EJ, Hess JL, Pear WS, and Hua X (2006). The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc Natl Acad Sci USA 103, 1018-10123.
5. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC, Hayes DN, Shanmugam KS, Bhattacharjee A, Biondi CA, et al. (2004). Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13, 587-597.
6. INK4c. Proc Natl Acad Sci USA 102, 14659-14664.
7. La P, Desmond A, Hou Z, Silva AC, Schnepp RW, and Hua X (2006). Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression. Oncogene 25, 3537-3546.
8. Lin SY and Elledge SJ (2003). Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881-889.
9. Milne TA, Dou Y, Martin ME, Brock HW, Roeder RG, and Hess JL (2005). MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci USA 102, 14765-14770.
10. Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, and Cleary ML (2005). The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123, 207-218.
11. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, et al. (2005). Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 102, 749-754.
12. La P, Schnepp RW, Petersen D, Silva C, and Hua A (2004). Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2. Endocrinology 145, 3443-3450.
13. Schnepp RW, Mao H, Sykes SM, Zong WX, Silva A, La P, and Hua X (2004). Menin induces apoptosis in murine embryonic fibroblasts. J Biol Chem 279, 10685-10691.
14. Stalberg P, Grimfjard P, Santesson M, Zhou Y, Lindberg D, Gobl A, Oberg K, Westin G, Rastad J, Wang S, et al. (2004). Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1. J Clin Endocrinol Metab 89, 2326-2337.
15. Dilley WG, Kalyanaraman S, Verma S, Cobb JP, Laramie JM, and Lairmore TC (2005). Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome. Mol Cancer 4, 9.
16. Forsberg L, Bjorck E, Hashemi J, Zedenius J, Hoog A, Farnebo LO, Reimers M, and Larsson C (2005). Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology. Eur J Endocrinol 152, 459-470.
17. Chen J and Sadowski I (2005). Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc Natl Acad Sci USA 102, 4813-4818.
18. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM, McWeeney S, Dunn JJ, Mandel G, and Goodman RH (2004). Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119, 1041-1054.
19. Kim J, Bhinge AA, Morgan XC, and Iyer VR (2005). Mapping DNA-protein interactions in large genomes by sequence tag analysis of genomic enrichment. Nat Methods 2, 47-53.
20. Sikder D and Kodadek T (2005). Genomic studies of transcription factor-DNA interactions. Curr Opin Chem Biol 9, 38-45.
21. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, et al. (2006). A global map of p53 transcription-factor binding sites in the human genome. Cell 124, 207-219.
22. Saha S, Sparks AB, Rago C, Akmaev V, Wang CJ, Vogelstein B, Kinzler KW, and Velculescu VE (2002). Using the transcriptome to annotate the genome. Nat Biotechnol 20, 508-512.
23. Ewing B and Green P (1998). Base-calling of automated sequencer traces using phred: II. Error probabilities. Genome Res 8, 186-194.
24. Wu SM, Baxendale V, Chen Y, Pang AL, Stitely T, Munson PJ, Leung MY, Ravindranath N, Dym M, Rennert OM, et al. (2004). Analysis of mouse germ-cell transcriptome at different stages of spermatogenesis by SAGE: biological significance. Genomics 84, 971-981.
25. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W, and Cleary ML (2004). Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24, 5639-5649.
26. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS, et al. (2006). Genome-wide analysis of menin binding provides insights to MEN1 tumorigenesis. PLoS Genet 2, e51.
27. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, et al. (1999). Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96, 143-152.
28. Knapp JI, Heppner C, Hickman AB, Burns AL, Chandrasekharappa SC, Collins FS, Marx SJ, Spiegel AM, and Agarwal SK (2000). Identification and characterization of JunD missense mutants that lack menin binding. Oncogene 19, 4706-4712.
29. Zhou H, Zarubin T, Ji Z, Min Z, Zhu W, Downey JS, Lin S, and Han J (2005). Frequency and distribution of AP-1 sites in the human genome. DNA Res 12, 139-150.
30. Zhang Y, Feng XH, and Derynck R (1998). Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394, 909-913.
31. Lieb JD and Clarke ND (2005). Control of transcription through intragenic patterns of nucleosome composition. Cell 123, 1187-1190.
32. Engstrom PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G, Brozzi A, Luzi L, Tan SL, Yang L, et al. (2006). Complex Loci in human and mouse genomes. PLoS Genet 2, e47.
33. Beissbarth T and Speed TP (2004). GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20, 1464-1465.
34. Hayakawa J, Mittal S, Wang Y, Korkmaz KS, Adamson E, English C, Ohmichi M, McClelland M, and Mercola D (2004). Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell 16, 521-535.
35. Agarwal SK, Novotny EA, Crabtree JS, Weitzman JB, Yaniv M, Burns AL, Chandrasekharappa SC, Collins FS, Spiegel AM, and Marx SJ (2003). Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci USA 100, 10770-10775.